16 Matching Annotations
  1. Last 7 days
  2. link.springer.com link.springer.com
    KDM6A loss enhances oxidative phosphorylation uncovering tissue-level convergent evolution
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1038/s44318-026-00891-0
  3. May 2026
  4. www.sciencedirect.com www.sciencedirect.com
    Covalent PPARγ inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARγ/RXRα-activated urothelial carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945626001522
  5. Apr 2026
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13042393/
  7. Mar 2026
  8. www.sciencedirect.com www.sciencedirect.com
    Reconstruction of T cell infiltration in an osteosarcoma PDX-organoid interactive biobank for personalized immunotherapy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379126000613
  9. Sep 2025
  10. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    PIN1 prolyl isomerase promotes initiation and progression of bladder cancer through the SREBP2-mediated cholesterol biosynthesis pathway
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11875963/
  11. Jun 2025
  12. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12167931/
  13. Dec 2024
  14. pubs.acs.org pubs.acs.org
    Preclinical Evaluation of an Al18F‑Radiolabeled Bicyclic Peptide Targeting Nectin‑4
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    pubs.acs.org/doi/10.1021/acs.molpharmaceut.4c00858
  15. Nov 2024
  16. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    IMP2 drives chemoresistance by repressing cisplatin-induced apoptosis and ferroptosis via activation of IPO4 and SLC7A11 under hypoxia in bladder cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11583454/
  17. Aug 2024
  18. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Role of Forkhead Box P3 in Interferon γ-mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11345674/
  19. cellandbioscience.biomedcentral.com cellandbioscience.biomedcentral.com
    PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    cellandbioscience.biomedcentral.com/articles/10.1186/s13578-023-00997-6
  20. Apr 2023
  21. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10112292/
  22. Mar 2023
  23. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10015223/
  24. Apr 2022
  25. aacrjournals.org aacrjournals.org
    Development of novel aptamer-based targeted chemotherapy for bladder cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerres/article/82/6/1128/682057/Development-of-Novel-Aptamer-Based-Targeted
  26. Jun 2021
  27. www.cell.com www.cell.com
    p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/iscience/abstract/S2589-0042(21)00669-6
  28. Sep 2020
  29. onlinelibrary.wiley.com onlinelibrary.wiley.com
    Novel engineered TRAIL‐based chimeric protein strongly inhibits tumor growth and bypasses TRAIL resistance
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/ijc.32845